
About Veerhealth Care Limited
Data last updated:
Veerhealth Care Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 10 July 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L65910MH1992PLC067632. Its GSTIN is 27AAACN1407B1Z6 (Maharashtra). The company holds 2 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on BSE: 511523.
The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹20 Cr. It was formerly known as Niyati Industries Limited. It is led by directors including Bhavin Satish Shah (Managing Director) and Nilesh Kantilal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹32.48 Cr, a growth of 94.8% compared to the previous year. For the same year it recorded a net profit of ₹68 Lakh (net margin 2.1%) and EBITDA of ₹2.15 Cr (EBITDA margin 6.6%). The net worth stands at ₹22.92 Cr (up 3.2% YoY). Total assets are valued at ₹30.16 Cr (up 0.4% YoY).
The company has about 5 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Veerhealth Care. As per MCA filings, the company has open charges of ₹7.5 Cr and satisfied charges of ₹7.37 Cr on record. Court records list 13 cases involving the company, including 5 filed by the company and 8 filed against it; 2 cases are pending. The company has 183 deals on record (183 market trades); the latest was in August 2026. Its 6 peer companies in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Fabino Enterprises Limited with revenue of ₹18.33 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website veerhealthcare.net.
Company details
Contact details
Veerhealth Care Limited's registered office is in Mumbai, Maharashtra. Its website is veerhealthcare.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address629 – A 1st Floor Gazdar House Dhobi Talao Jagannath Shankarsheth Marg Kalbadevi P, Ost Office, Mumbai, Maharashtra, India – 400002
- IndustryE-Commerce, Online Healthcare Product Retail
To see the full contact details of Veerhealth Care Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Veerhealth Care operates one associated brand: Veerhealth Care. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of ayurveda medicinal products | veerhealthcare.net |
Business activity
The main business activity of Veerhealth Care is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Veerhealth Care Limited, buy the company report.
Financials of Veerhealth Care Limited
FY 2025-26 filings availableVeerhealth Care Limited reported revenue of ₹32.48 Cr (up 94.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 32.48 | 16.67 | 13.22 | 13.27 | 9.63 | 10.58 | 11.73 |
| Revenue growth | +94.8% | +26.1% | -0.4% | +37.8% | -9.0% | -9.8% | - |
| EBITDA | 2.15 | 0.46 | 0.60 | 0.50 | (0.81) | 0.07 | 0.68 |
| EBITDA margin | +6.6% | +2.8% | +4.5% | +3.8% | -8.4% | +0.7% | +5.8% |
| Profit before tax | 1.26 | 0.51 | 1.27 | 1.12 | 0.25 | 0.58 | 0.65 |
| Net profit | 0.68 | 0.39 | 0.39 | 1.58 | (0.06) | 0.38 | 0.32 |
| Net profit margin | +2.1% | +2.3% | +3.0% | +11.9% | -0.6% | +3.6% | +2.7% |
| EPS (₹) | 0.27 | 0.20 | 0.20 | 1.58 | (0.11) | 0.55 | 0.46 |
| Balance sheet | |||||||
| Total assets | 30.16 | 30.05 | 24.61 | 24.13 | 16.88 | 16.96 | 16.46 |
| Net worth | 22.92 | 22.22 | 21.84 | 21.43 | 13.95 | 14.04 | 13.75 |
| Total debt | 4.58 | 4.91 | 0.00 | 0.00 | 0.00 | 1.73 | 2.48 |
| Cash & bank | 0.46 | 1.16 | 0.24 | 3.61 | 0.40 | 0.10 | 0.02 |
| Net working capital | 5.82 | 5.81 | 10.69 | 9.37 | 3.76 | 5.57 | 5.14 |
| Cash flow | |||||||
| Cash from operations | 4.19 | 4.51 | 2.90 | (0.70) | 1.81 | 1.00 | (0.36) |
| Cash from investing | (4.43) | (8.20) | (0.28) | (1.79) | (1.09) | (0.09) | (1.67) |
| Cash from financing | (0.46) | 4.61 | (5.99) | 5.69 | (0.42) | (0.83) | 1.85 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.35 | 24.93 | 16.76 | 7.26 | 3.98 | 4.49 | 5.62 | 3.84 |
| Revenue growth (YoY) | +461.6% | +455.2% | +198.2% | +89.1% | -22.7% | +118.0% | - | - |
| Other income | 0.19 | 0.16 | 0.22 | (0.29) | 0.23 | 0.65 | 0.43 | 0.18 |
| Total expenses | 20.50 | 23.02 | 16.34 | 6.02 | 3.45 | 4.52 | 5.78 | 3.68 |
| EBITDA | 1.85 | 1.91 | 0.42 | 1.24 | 0.53 | (0.03) | (0.16) | 0.16 |
| EBITDA margin | +8.3% | +7.7% | +2.5% | +17.1% | +13.3% | -0.7% | -2.8% | +4.2% |
| Depreciation | 0.41 | 0.36 | 0.35 | 0.35 | 0.31 | 0.28 | 0.26 | 0.25 |
| Interest | 0.20 | 0.23 | 0.11 | 0.10 | 0.10 | 0.10 | 0.14 | 0.01 |
| Profit before tax | 1.43 | 1.48 | 0.18 | 0.50 | 0.35 | 0.24 | (0.13) | 0.08 |
| Tax | 0.23 | 0.25 | 0.53 | 0.09 | 0.09 | 0.00 | (0.03) | 0.00 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.35 | 24.93 | 16.76 | 7.26 | 3.98 | 4.49 | 5.62 | 3.84 |
| Revenue growth (YoY) | +461.6% | +455.2% | +198.2% | +89.1% | -22.7% | +118.0% | - | - |
| Other income | 0.19 | 0.16 | 0.22 | (0.29) | 0.23 | 0.65 | 0.43 | 0.18 |
| Total expenses | 20.50 | 23.02 | 16.34 | 6.02 | 3.45 | 4.52 | 5.78 | 3.68 |
| EBITDA | 1.85 | 1.91 | 0.42 | 1.24 | 0.53 | (0.03) | (0.16) | 0.16 |
| EBITDA margin | +8.3% | +7.7% | +2.5% | +17.1% | +13.3% | -0.7% | -2.8% | +4.2% |
| Depreciation | 0.41 | 0.36 | 0.35 | 0.35 | 0.31 | 0.28 | 0.26 | 0.25 |
| Interest | 0.20 | 0.23 | 0.11 | 0.10 | 0.10 | 0.10 | 0.14 | 0.01 |
| Profit before tax | 1.43 | 1.48 | 0.18 | 0.50 | 0.35 | 0.24 | (0.13) | 0.08 |
| Tax | 0.23 | 0.25 | 0.53 | 0.09 | 0.09 | 0.00 | (0.03) | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 32.48 | 16.67 | 13.22 | 13.27 | 9.63 | 10.58 | 11.73 |
| Revenue growth | +94.8% | +26.1% | -0.4% | +37.8% | -9.0% | -9.8% | - |
| Other income | 0.80 | 1.22 | 1.39 | 1.24 | 1.67 | 1.20 | 0.48 |
| Total expenses | 30.33 | 16.21 | 12.62 | 12.77 | 10.44 | 10.51 | 11.05 |
| Employee cost | 0.00 | 1.58 | 1.31 | 0.90 | 0.88 | 0.83 | 0.80 |
| EBITDA | 2.15 | 0.46 | 0.60 | 0.50 | (0.81) | 0.07 | 0.68 |
| EBITDA margin | +6.6% | +2.8% | +4.5% | +3.8% | -8.4% | +0.7% | +5.8% |
| Depreciation | 1.29 | 0.91 | 0.71 | 0.62 | 0.52 | 0.47 | 0.32 |
| Interest | 0.40 | 0.26 | 0.01 | 0.00 | 0.09 | 0.22 | 0.19 |
| Profit before tax | 1.26 | 0.51 | 1.27 | 1.12 | 0.25 | 0.58 | 0.65 |
| Tax | 0.71 | 0.12 | 0.88 | (0.46) | 0.31 | 0.20 | 0.33 |
| Net profit | 0.68 | 0.39 | 0.39 | 1.58 | (0.06) | 0.38 | 0.32 |
| Net profit margin | +2.1% | +2.3% | +3.0% | +11.9% | -0.6% | +3.6% | +2.7% |
| EPS (₹) | 0.27 | 0.20 | 0.20 | 1.58 | (0.11) | 0.55 | 0.46 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 20.00 | 20.00 | 20.00 | 10.00 | 6.93 | 6.93 | 6.93 |
| Reserves & surplus | 2.92 | 2.22 | 1.84 | 11.43 | 7.02 | 7.11 | 6.82 |
| Shareholders' funds (net worth) | 22.92 | 22.22 | 21.84 | 21.43 | 13.95 | 14.04 | 13.75 |
| Secured loans | 4.58 | 4.91 | 0.00 | 0.00 | 0.00 | 1.73 | 2.48 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 4.58 | 4.91 | 0.00 | 0.00 | 0.00 | 1.73 | 2.48 |
| Total liabilities | 30.16 | 30.05 | 24.61 | 24.13 | 16.88 | 16.96 | 16.46 |
| Assets | |||||||
| Gross block | 29.70 | 24.85 | 16.03 | 15.05 | 12.96 | 11.37 | 10.88 |
| Net block | 23.43 | 19.87 | 11.97 | 12.01 | 10.54 | 9.48 | 9.45 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 4.45 | 2.44 | 1.40 | 2.61 | 2.12 | 1.66 | 1.23 |
| Sundry debtors | 9.74 | 0.98 | 3.92 | 1.84 | 1.54 | 1.54 | 0.94 |
| Cash & bank balances | 0.46 | 1.16 | 0.24 | 3.61 | 0.40 | 0.10 | 0.02 |
| Loans & advances | 3.82 | 4.07 | 7.90 | 2.28 | 2.16 | 3.53 | 4.00 |
| Total current assets | 18.47 | 8.65 | 13.46 | 10.34 | 6.22 | 6.83 | 6.19 |
| Total current liabilities | 12.65 | 2.84 | 2.77 | 0.97 | 2.46 | 1.26 | 1.05 |
| Net working capital | 5.82 | 5.81 | 10.69 | 9.37 | 3.76 | 5.57 | 5.14 |
| Total assets | 30.16 | 30.05 | 24.61 | 24.13 | 16.88 | 16.96 | 16.46 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 1.16 | 0.24 | 3.61 | 0.40 | 0.10 | 0.02 | 0.18 |
| Net cash from operating activities | 4.19 | 4.51 | 2.90 | (0.70) | 1.81 | 1.00 | (0.36) |
| Net cash from investing activities | (4.43) | (8.20) | (0.28) | (1.79) | (1.09) | (0.09) | (1.67) |
| Net cash from financing activities | (0.46) | 4.61 | (5.99) | 5.69 | (0.42) | (0.83) | 1.85 |
| Net change in cash | (0.70) | 0.92 | (3.37) | 3.21 | 0.30 | 0.09 | (0.17) |
| Closing cash | 0.46 | 1.16 | 0.24 | 3.61 | 0.40 | 0.10 | 0.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +94.8% | +26.1% | -0.4% | +37.8% | -9.0% | -9.8% | - |
| EBITDA growth | +367.4% | -23.3% | +20.0% | +161.7% | -1257.1% | -89.7% | - |
| PBT growth | +103.2% | -51.2% | +13.4% | +348.0% | -56.9% | -10.8% | +71.1% |
| Net income growth | +74.4% | 0.0% | -75.3% | +2733.3% | -115.8% | +18.8% | - |
| Revenue CAGR (3Y) | +34.8% | +20.6% | +7.7% | +4.2% | +17.2% | +27.0% | +82.8% |
| EBITDA CAGR (3Y) | +62.6% | - | +104.7% | -9.7% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +1.7% | +2.3% | +3.0% | +11.9% | -0.6% | +3.6% | +2.7% |
| Return on capital employed | +6.5% | +3.2% | +5.3% | +5.4% | +2.0% | +4.8% | +5.4% |
| Return on net worth | +3.0% | +1.8% | +1.9% | +8.9% | -0.5% | +2.7% | +2.4% |
| Debt / equity | 0.21 | 0.11 | 0.00 | 0.00 | 0.06 | 0.15 | 0.13 |
| Long-term debt / equity | 0.18 | 0.10 | 0.00 | 0.00 | 0.05 | 0.12 | 0.08 |
| Interest cover | 46.51 | -185.71 | -9.09 | 0.00 | -6.77 | -55.00 | 52.78 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.19 | 0.83 | 0.85 | 0.95 | 0.79 | 0.95 | 1.34 |
| Inventory turnover | 9.43 | 8.79 | 6.59 | 5.61 | 5.10 | 7.32 | 11.33 |
| Debtors turnover | 6.06 | 6.89 | 4.59 | 7.85 | 6.25 | 8.53 | 13.96 |
| EPS (₹) | 0.27 | 0.20 | 0.20 | 1.58 | (0.11) | 0.55 | 0.46 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 11.46 | 11.11 | 10.92 | 21.43 | 20.12 | 20.25 | 19.84 |
To see the full year-wise statements and ratios of Veerhealth Care Limited, buy the company report.
Board of directors and KMP of Veerhealth Care Limited
Veerhealth Care Limited currently reports 6 directors and 1 key managerial person. 10 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilesh Kantilal Shah | Director | 14 Aug 2023 | 3 Years 3 Months | Current |
| Yogesh Mahasukhlal Shah Also directs: Veer Energy & Infrastructure Limited, Sanskar Dham Vidhyalay Foundation, Ayuveer Foundation and 1 more | Director | 15 Jun 2011 | 15 Years 5 Months | Current |
| Chetan Hasmukhlal Mehta Also directs: Ayuveer Vidhyalay Foundation | Director | 14 Aug 2023 | 3 Years 3 Months | Current |
| Akash Prakash Shah Also directs: Ayuveer Industries Private Limited | Cfo | 10 Feb 2017 | 9 Years 9 Months | Current |
| Prakashbhai Chandulal Shah Also directs: CDS Supply Chain LLP | Director | 14 Aug 2023 | 3 Years 3 Months | Current |
| Shruti Yogesh Shah Also directs: Ayuveer Foundation, Ayuveer Industries Private Limited | Director | 12 Sep 2014 | 12 Years 2 Months | Current |
Peer comparison
Veerhealth Care Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Veerhealth Care Limitedthis company | ₹32.48 Cr (FY 2026) | ₹68 Lakh | 2.1% | 94.8% | 5 | Mumbai, Maharashtra, India |
| Fabino Enterprises Limited | ₹18.33 Cr (FY 2025) | -13.0% | Sonipat, Haryana, India | |||
| Dhathri Life Sciences Private Limited | ₹18.11 Cr (FY 2024) | 9.0% | Kayamkulam, Kerala, India | |||
| Girnar Ayurvedic Pharmacy Private Limited | ₹17.85 Cr (FY 2024) | -8.0% | Ahmedabad, Gujarat, India | |||
| Sakti Naturals Private Limited | ₹17.49 Cr (FY 2024) | 11.0% | Villupuram, Tamil Nadu, India | |||
| Sana Herbals Pvt. Ltd. | ₹17.47 Cr (FY 2024) | 1.0% | New Delhi, Delhi, India | |||
| Kniss Laboratories Private Limited | ₹17.41 Cr (FY 2023) | -13.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Veerhealth Care Limited, buy the company report.
Auditor
Veerhealth Care Limited is audited by Jayesh R. Shah & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Jayesh R. Shah & Co. | FY 2023 | 104182W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 31.90%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 68.10%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 31.90% | 31.50% | 31.50% | 31.50% |
| Public | 68.10% | 68.50% | 68.50% | 68.50% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Sep 2024 | 100996616 | Others | ₹7.5 Cr | Open | |
| 17 Dec 2020 | 100394922 | Sidbi | ₹47.09 Lakh | Satisfied | |
| 27 Dec 2019 | 100314216 | Hdfc Bank Limited | ₹2 Cr | Satisfied | |
| 23 Jul 2019 | 100278482 | Sidbi | ₹2.9 Cr | Satisfied | |
| 31 Dec 2014 | 10539830 | Hdfc Bank Limited | ₹2 Cr | Satisfied |
To see the full charge records of Veerhealth Care Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Veerhealth Care Limited has 183 deals on record (183 market trades); the latest was in August 2026.
Deals on record (5 of 183)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2026 | Market trade | ₹25.4 Lakh | Buyer: an individual Seller: Ishaan Tradefin LLP |
| Sep 2025 | Market trade | ₹18 Lakh | Buyer: Rishabh Fintrade Ltd Seller: an individual |
| Sep 2025 | Market trade | ₹18.1 Lakh | Buyer: Rishabh Fintrade Ltd Seller: an individual |
| Sep 2025 | Market trade | ₹18.6 Lakh | Buyer: Rishabh Fintrade Ltd Seller: an individual |
| Feb 2024 | Market trade | ₹52.7 Lakh | Buyer: Shubham Financial Services Seller: Dhwaja Shares & Securities Private Limited |
To see the full deal history of Veerhealth Care Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Veerhealth Care Limited has 13 court cases on record: 5 filed by Veerhealth Care, 8 filed against it. 2 cases are pending and 11 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 4 | 1 |
| High courts | 3 | 3 | 0 |
| Supreme Court | 3 | 1 | 1 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1301-Consumer Disputes and RERA : Appeals under Section 23 of Consumer Protection Act, 1986 and/or under Section 67 of Consumer Protection Act, 2019) | Filed by the company against M/S National Insurance Co. Ltd. | Disposed |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed against the company by M/S Tommorrowland Limited | Pending |
| High Court of Delhi | Court case (FAO(OS)) | Filed against the company by Tommorrowland Limited | Disposed |
| District court, New Delhi, Delhi | Interim or miscellaneous application | Filed by the company against Pasupati Fabrics Ltd. | Disposed |
| District court, New Delhi, Delhi | Arbitration matter | Filed by the company against Pasupati Fabrics Ltd | Disposed |
To see the full case history of Veerhealth Care Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Veerhealth Care Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Veerhealth Care Limited has a workforce of 5 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 5 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Veerhealth Care Limited, buy the company report.
GST
Veerhealth Care has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACN1407B1Z6 | Maharashtra | Active | 01 Jul 2017 |
| 24AAACN1407B1ZC | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Veerhealth Care Limited, buy the company report.
Recent activity
Veerhealth Care Limited has 17 board changes on record since 2009: 7 appointments and 10 cessations. The latest: Arvind Maganlal Shah ceased to be Director on 31 Mar 2024.
19 earlier events are in the company report.
News
Frequently asked questions
Veerhealth Care is an active public limited company based in Mumbai, Maharashtra, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 10 July 1992 (34+ years old) and is registered under CIN L65910MH1992PLC067632. Listed on BSE: 511523.
Veerhealth Care reported revenue of ₹32.48 Cr for FY 2025-26 (up 94.8% YoY) based on standalone financials.
Veerhealth Care has 7 current directors and KMP:
- Bhavin Satish Shah - Managing Director
- Nilesh Kantilal Shah - Director
- Yogesh Mahasukhlal Shah - Director
- Chetan Hasmukhlal Mehta - Director
- Prakashbhai Chandulal Shah - Director
- Shruti Yogesh Shah - Director
- Akash Prakash Shah - Cfo
The latest financial statements of Veerhealth Care on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Veerhealth Care is 27AAACN1407B1Z6, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACN1407B1ZC (Gujarat).
The CIN (Corporate Identification Number) of Veerhealth Care is L65910MH1992PLC067632. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Veerhealth Care is a listed company as per MCA records. Its shares are listed on BSE (code: 511523).
Veerhealth Care has 13 court cases on record: 5 filed by the company and 8 filed against it. 2 are pending. Most are in the district courts.
Veerhealth Care was incorporated on 10 July 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
Veerhealth Care has 183 deals on record (183 market trades); the latest was in August 2026.
The peers of Veerhealth Care by revenue are Fabino Enterprises Limited, Dhathri Life Sciences Private Limited, Girnar Ayurvedic Pharmacy Private Limited, Sakti Naturals Private Limited, Sana Herbals Pvt. Ltd. and 1 more, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

